Zimmer Biomet Holdings, Inc. Financials

Market Capitalization $22.10 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	21.19
Forward PE	12.91
Price to Sales TTM	$2.91
Price to Book MRQ	$1.79
Enterprise to Revenue	3.71
Enterprise to EBITDA	11.02

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	14.27%
Operating Margin	18.00%
Return on Assets TTM	4.61%
Return on Equity TTM	8.71%

Income Statement

Revenue TTM	$7,595,500,032
Revenue per Share TTM	$37.01
Quarterly Revenue Growth	4.00%
Gross Profit TTM	$5,460,800,000
EBITDA	$2,487,100,000
Net Income to Common TTM	$1,083,500,032
Diluted EPS TTM	$5.24
Quarterly Earnings Growth YoY	53.10%

Balance Sheet

Total Cash MRQ	$569,000,000
Total Cash per Share MRQ	$2.86
Total Debt MRQ	$
Total Debt to Equity MRQ	53.61
Current Ratio MRQ	1.36
Book Value per Share MRQ	$62.00

Cash Flow

Operating Cash Flow TTM	$1,581,500,032
Levered Free Cash Flow TTM	$1,221,187,456

ZBH Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	199,074,000
Float Shares	198,548,157
Avg 10 Volume	1,960,230
Avg 30 Volume	None
Shares Short	7,336,497
Short Ratio	4.89
Short % of Shares	4.19%
% Held by Insiders	0.14%
% Held by Institutions	93.09%

Stock Price Summary

Beta	1.02
Fifty Two Week Low	$100.67
Fifty Two Week High	$133.90
Fifty Two Week Change	-10.93%
Day 50 MA	$108.10
Day 200 MA	$110.62

Dividends and Splits

Forward Annual Dividend Rate	$0.96
Forward Annual Dividend Yield	0.87%
Trailing Annual Dividend Rate	$0.96
Trailing Annual Dividend Yield	0.87%
Payout Ratio	18.32%
Dividend Date	2025-01-31
Ex Dividend Date	2024-12-30
Last Split Factor
Last Split Date	2022-03-01